Colorado Springs, COLORADO2 Active Studies

Hereditary Angioedema Clinical Trials in Colorado Springs, COLORADO

Find 2 actively recruiting hereditary angioedema clinical trials in Colorado Springs, COLORADO. Connect with local research sites and explore new treatment options.

2
Active Trials
2
Sponsors
265
Enrolling

Recruiting Hereditary Angioedema Studies in Colorado Springs

About Hereditary Angioedema Clinical Trials in Colorado Springs

Hereditary angioedema (HAE) is a rare genetic condition causing recurrent episodes of severe swelling in various body parts. It is caused by deficiency or dysfunction of C1 inhibitor protein. Treatment includes on-demand therapy for attacks and prophylactic medications to prevent episodes.

There are currently 2 hereditary angioedema clinical trials recruiting participants in Colorado Springs, COLORADO. These studies are seeking a combined 265 participants. Research is being sponsored by Astria Therapeutics, Inc., Pharvaris Netherlands B.V.. Clinical trial participation is free and participants receive study-related medical care at no cost.

Hereditary Angioedema Clinical Trials in Colorado Springs — FAQ

Are there hereditary angioedema clinical trials in Colorado Springs?

Yes, there are 2 hereditary angioedema clinical trials currently recruiting in Colorado Springs, COLORADO. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Colorado Springs?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Colorado Springs research site will contact you about next steps.

Are clinical trials in Colorado Springs free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Colorado Springs studies also compensate for your time and travel.

What hereditary angioedema treatments are being tested?

The 2 active trials in Colorado Springs are testing new therapies including novel drugs, biologics, and treatment approaches for hereditary angioedema.

Data updated March 2, 2026 from ClinicalTrials.gov